Singapore markets closed
  • Straits Times Index

    +2.80 (+0.11%)
  • S&P 500

    -7.56 (-0.22%)
  • Dow

    -97.97 (-0.35%)
  • Nasdaq

    -31.80 (-0.28%)

    +1,810.69 (+16.38%)
  • CMC Crypto 200

    +13.25 (+5.41%)
  • FTSE 100

    -22.34 (-0.39%)
  • Gold

    -10.00 (-0.52%)
  • Crude Oil

    +0.18 (+0.45%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Nikkei

    -165.19 (-0.70%)
  • Hang Seng

    +31.71 (+0.13%)
  • FTSE Bursa Malaysia

    +6.40 (+0.43%)
  • Jakarta Composite Index

    -4.63 (-0.09%)
  • PSE Index

    +66.04 (+1.05%)

Global Extra Corporeal Membrane Oxygenation (ECMO) System Market to 2028 - Advancement in Technology Presents Opportunities -

·4-min read

The "Global Extra Corporeal Membrane Oxygenation (ECMO) System Market 2019-2028" report has been added to's offering.

According to this report the global extracorporeal membrane oxygenation (ECMO) market is predicted to grow at a CAGR of 4.81% during the forecasting period 2019-2028.

The rising popularity of the ECMO technology owing to its rising applications and the advancement in the technology are contributing to the global market growth. Besides, the rising prevalence of chronic diseases like cardiovascular diseases and respiratory diseases, are also driving the demand for the ECMO market. The government and other organizations are implementing several initiatives to create awareness about these systems. However, the huge cost of the ECMO systems is likely to restrain market growth. Alternative techniques like anti-inflammatory therapy and vaccination, used for the treatment of respiratory and cardiopulmonary diseases, are also impeding the global market growth. Lack of experienced laborers is also challenging the growth of the ECMO system market.

The global market report covers the countries from North America, Europe, the Asia-Pacific, Latin America and the Middle East and Africa.

North America is expected to be the largest ECMO system market in the forecast period. The burden of cardiovascular diseases is growing rapidly in the North American countries like the United States. This is due to the rise in cases of high blood pressure, rising prevalence of obesity, an alarming rise in type-2 diabetes and poor diet & unhealthy lifestyles, which are the significant risk factors for stroke and heart diseases. According to the Centres for Disease Control and Prevention (CDC), in 2016, cardiovascular disease was said to be the leading cause of death in the United States. All these factors are fueling the demand for extracorporeal membrane oxygenation (ECMO) systems in this region.


The major companies in the extracorporeal membrane oxygenation (ECMO) market are Eurosets, Terumo Medical Corporation, MicroPort Scientific Corporation, Xenios AG (Fresenius SE & Co KGaA), Medtronic Plc, LivaNova Plc, ALung Technologies Inc, Elsius Biomedical Inc, Nipro Corporation, OriGen Biomedical Inc, Spectrum Medical, Getinge AB, Abbott Laboratories and Hemovent GmbH.

Established in 2015, by a merger between Cyberonics Inc and Sorin SpA, LivaNova Plc is a global company providing cardiovascular and neuromodulation solutions. The company is dedicated to offering meaningful products and therapies that will benefit public health. It aims to provide hope for patients through innovative medical solutions. Lilliput 2 ECMO is a product from the Lilliput oxygenators' family. It aids neonatal and infant patients with optimal performance to undergo long-duration surgeries. EOS ECMO is another product provided by the company that comes with a plasma tight polymethyl pentene (PMP) hollow fiber, providing stability during long surgical procedures.

Key Topics Covered:

1. Global Extra Corporeal Membrane Oxygenation (Ecmo) System Market - Summary

2. Industry Outlook

2.1. Market Definition

2.2. Porter's Five Forces Model

2.3. Impact of Covid-19 on ECMO System Market

2.4. Market Attractiveness Index

2.5. Vendor Scorecard

2.6. Key Insights

2.7. Market Drivers

2.7.1. Rising Popularity of ECMO Technology

2.7.2. Increasing Prevalence of Chronic Disorders

2.8. Market Restraints

2.8.1. Significant Cost of ECMO Systems

2.8.2. Existence of Alternative Techniques

2.9. Market Opportunities

2.9.1. Growing Awareness Regarding Applications of ECMO Systems

2.9.2. Advancement in Technology

2.10. Market Challenges

2.10.1. Lack of Specialized Skills for Operation

2.10.2. Risks Associated With ECMO Procedures

3. Extra Corporeal Membrane Oxygenation (Ecmo) System Market Outlook - by Application

3.1. Respiratory

3.2. Cardiac

3.3. Extracorporeal Cardiopulmonary Resuscitation (Ecpr)

4. Extra Corporeal Membrane Oxygenation (Ecmo) System Market Outlook - by Modality

4.1. Veno-Venous

4.2. Veno-Arterial

4.3. Other Modalities

5. Extra Corporeal Membrane Oxygenation (Ecmo) System Market - Regional Outlook

5.1. North America

5.2. Europe

5.3. Asia-Pacific

5.4. Latin America

5.5. Middle East and Africa

6. Company Profiles

6.1. Hemovent GmbH

6.2. Livanova plc

6.3. Microport Scientific Corporation

6.4. Terumo Medical Corporation

6.5. Elsius Biomedical Inc

6.6. Abbott Laboratories

6.7. Alung Technologies Inc

6.8. Eurosets

6.9. Spectrum Medical

6.10. Xenios AG (Fresenius SE & Co KGAA)

6.11. Medtronic plc

6.12. Getinge Ab

6.13. Nipro Corporation

6.14. Origen Biomedical Inc

7. Research Methodology & Scope

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900